Subchondral Solutions, Inc. Receives Innovative Technology Contract from Vizient for Subchondral Solutions – S-Core® Joint Preservation Platform

Subchondral Solutions, Inc. Receives Innovative Technology Contract from Vizient for Subchondral Solutions – S-Core® Joint Preservation Platform

September 10, 2024

Contract awarded for products that bring improvement to healthcare industry

Costa Mesa, CA, September 1, 2024– Subchondral Solutions, Inc. announced that its S-Core® Joint Preservation Platform has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of hospital experts who serve on one of Vizient’s customer-led councils, and it signifies to Vizient provider customers unique qualities that potentially bring improvement to the healthcare industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient customer-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety or improve business operations of healthcare organizations.

“We are thrilled to have the opportunity to work with Vizient, not only because Vizient is the largest provider-driven healthcare performance improvement company in the US, but that it also has strong relationships with the most recognized academic institutions in the world,” said Thomas Kinder, CEO of Subchondral Solutions. “The Subchondral Solutions S-Core® Joint Preservation Platform was designed to slow down the progression of osteoarthritis. Osteoarthritis affects almost 50% of the adult population in the US and this condition severely limits the activity level of these patients. S-Core® helps the patients to stay active improving their quality of life and helps them to maintain their overall health. The S-Core®

Joint Preservation Platform has accomplished this goal and has shown to be durable in the major joints in the upper and lower extremity as well in sports medicine.”

“The Innovative Technology Exchange fosters a unique opportunity for healthcare providers to interact with products and services that have the potential to impact the healthcare industry and improve clinical care or business models of organizations,” said Kelly Flaharty, senior director of contract services, Vizient.

“We are pleased to invite Subchondral Solutions to the Exchange.”

Vizient represents a diverse customer base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and has a portfolio that represents more than $140 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with customer-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.


###


About Subchondral Solutions, Inc.

Subchondral Solutions was formed in 2015 and is committed to advancing joint preservation by addressing the source of the problem focusing on returning the biomechanical function to the damaged joint, with a durable and cost-effective scalable system. Contact us at info@subchondralsolutions.com.

An error has occurred. This application may no longer respond until reloaded. Reload 🗙